返回 Agenda
Session 1: Getting Ready for January 2025 – What is Already In Place And What Is Still To Come?
Session Chair(s)
Maya Matthews
Head of Unit State of Health, European Semester, Health Technology Assessment, European Commission , Belgium
Niklas Hedberg, MPharm
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
This session will provide updates from the different stakeholders on the activities already done to prepare for the application of the HTAR in January 2025 (HTA Coordination sub-groups, stakeholder network, EUnetHTA21 activities, patient and clinicians organization, national engagement, industry, etc.) and what is still in planning phase. In addition, stakeholders will exchange views on the key success factors for collectively ensuring a strong start into the application phase.
Speaker(s)
Maya Matthews
Head of Unit State of Health, European Semester, Health Technology Assessment, European Commission , Belgium
Niklas Hedberg, MPharm
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
Michael Berntgen, PhD
Head of Scientific Evidence Generation, European Medicines Agency, Netherlands
Alexander Natz, JD
Secretary General, European Confederation of Pharmaceutical Entrepreneurs, Belgium
Antonella Cardone
Director, Cancer Patients Europe, Belgium
Ansgar Hebborn, PhD, MBA
Head - Access Policy Affairs Europe, F. Hoffmann-La Roche AG, Switzerland